Locations:
Search IconSearch
December 5, 2023/Neurosciences/Podcast

Diagnosis and Management of Mitochondrial Diseases (Podcast)

Guidance on what should prompt a workup, current and emerging treatment options, and more

An estimated 1,000 to 4,000 children are born annually in the U.S. with a mitochondrial disease. There are at least 100 mitochondrial diseases, and symptoms are variable and often affect multiple body systems.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“We talk about mitochondria as energy production machines, but their role in the body ― in pathophysiology across all systems, across all specialties ― is huge,” says pediatric neurologist Sumit Parikh, MD, Director of Cleveland Clinic’s Mitochondrial Medicine Center. “As our understanding of mitochondria has grown, our understanding of their importance in other disease pathophysiology has grown significantly as well.”

In the latest episode of Cleveland Clinic’s Neuro Pathways podcast, Dr. Parikh talks about the diagnosis of mitochondrial diseases and guidelines for their management, as well as how experts are working to improve health outcomes for patients. He discusses:

  • Guidelines for patient evaluation developed by the Mitochondrial Medicine Society
  • The standardized workup for patients with symptoms of mitochondrial disease, including genetic testing
  • The challenges of mimicking diseases and misdiagnosis
  • Current treatment options and therapies on the horizon
  • His recent study analyzing mortality in patients with genetic mitochondrial diseases
  • The role of the Mitochondrial Care Network in helping providers

Click the podcast player above to listen to the episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts. This activity has been approved for AMA PRA Category 1 Credit™ and ANCC contact hours. After listening to the podcast, you can claim your credit here.

Excerpt from the podcast

Podcast host Glen Stevens, DO, PhD: In 2015, you led a team of mitochondrial disease experts that developed a standardized approach to evaluating patients with suspected mitochondrial disease. What should make us suspect a potential mitochondrial disorder? How do people generally present, or is the challenge that it’s so nonspecific?

Advertisement

Dr. Parikh: We really try to make it very straightforward for clinicians. The truth is that there are some findings that we consider red flags or sine qua non findings that still hold true. And for a busy clinician who is not seeing mitochondrial disease predominantly, who might be a generalist or a specialist, we really don’t want them to have to worry about all the individual diseases and symptoms and conditions.

The most high-impact symptoms are a combination of hearing loss and diabetes, whether in a pediatric patient or an adult patient. That alone is such an odd combination that if those are not well explained by some other condition or problem, that person deserves a workup for mitochondrial disease.

Looking more specifically at a neurology context, there are several findings that should prompt a workup for mitochondrial disease. These include unexplained lesions in the brain in a certain pattern ― specifically, a symmetric pattern in the deep gray matter, basal ganglia, thalami ― as well as unexplained strokes at a young age, unexplained cerebellar disease with volume loss and unexplained myoclonic epilepsy.

Advertisement

Related Articles

portrait of dr. demitre serletis against decorative background
December 2, 2024/Neurosciences/Podcast
SEEG in Epilepsy Surgery Evaluation: Current and Future Roles (Podcast)

Insights on how stereoelectroencephalography is continuing to improve seizure localization

William Clifton, MD, against a decorative background
November 4, 2024/Neurosciences/Podcast
Adult Idiopathic Scoliosis: Essentials of Diagnosis and Treatment (Podcast)

Early intervention yields the best outcomes, but surgery can benefit older patients as well

Creative illustration of a brain
October 16, 2024/Neurosciences/Podcast
Diagnosing Atypical Parkinsonian Disorders (Podcast)

Patient history plays a key role in identifying the condition

dr. daniel ontaneda against a decorative background
October 2, 2024/Neurosciences/Podcast
Takeaways From the New Diagnostic Criteria for Multiple Sclerosis (Podcast)

A co-author explains some of the key McDonald criteria revisions

Dr. Imad Najm against a decorative background
September 16, 2024/Neurosciences/Podcast
Temporal Lobe Epilepsy and the Potential of Gene Therapy (Podcast)

Investigational gene approaches offer hope for a therapeutically challenging condition

alison stout, DO, against a decorative backdrop
August 9, 2024/Neurosciences/Podcast
Evaluation and Interventional Treatment of Axial Lumbar Back Pain (Podcast)

This common condition remains tough to work up and diagnose, and treatment options are limited

Dr. Amy Kunchok against decorative background
July 16, 2024/Neurosciences/Podcast
What to Know About Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) (Podcast)

It’s time to get familiar with this emerging demyelinating disorder

receptor activity for myasthenia gravis medications
July 3, 2024/Neurosciences/Podcast
Myasthenia Gravis: Unmet Needs and Efforts to Address Them (Podcast)

An overview of associated antibodies, therapies for antibody-positive disease and the outlook for atypical forms of MG

Ad